Trademark: 97412560
Word
BENVIVA
Status
Dead
Status Code
606
Status Date
Monday, January 8, 2024
Serial Number
97412560
Mark Type
4000
Filing Date
Monday, May 16, 2022
Published for Opposition
Tuesday, April 11, 2023
Abandoned Date
Monday, January 8, 2024

Trademark Owner History
Benviva Inc. - Owner At Publication

Classifications
5 Pharmaceutical and biological preparations for use in humans for the treatment of bacterial infections, parasitic infections, viral infections, imunocomprimized infections; Biological preparations for human use, namely, biological tissue cultures for treating diseases of the cardiovascular system, diseases of the gastrointestinal system, ocular system, skeletal system, respiratory system, and skin;, namely, disorders of fibrosis and scarring, fibroids, hepatic fibrosis, pulmonary fibrosis, low grade scarring such as, increased fibrosis, keloids, post-surgical scars, wound healing, surgical scarring, fibrosclerosis, scar growth, keloid, fractures; Pharmaceutical and biological preparations for use in humans, namely, gene therapy, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy for treatment of genetic disorders, the musculo-skeletal system, namely, connective tissue disease, bone diseases, spinal diseases, rejection of grafts and transplants, and other rare diseases; Pharmaceutical and biological preparations for use in humans for the treatment of central nervous systems diseases, Alzheimer's, Parkinson's, respiratory track diseases, metabolic syndrome, cardiac diseases, skin diseases, cancer, high cholesterol, diabetes, sexually transmitted diseases, autoimmune diseases, multiple sclerosis, free radical oxidation; Pharmaceutical and biological preparations for veterinary medicine for the treatment of bacterial infections, parasitic infections, viral infections, imunocomprimized infections; Biological preparations for veterinary use, namely, biological tissue cultures for treating diseases of the cardiovascular system, diseases of the gastrointestinal system, diseases of the ocular system, diseases of the musculo-skeletal system, diseases of the respiratory system, and skin, namely, disorders of fibrosis and scarring, fibroids, hepatic fibrosis, pulmonary fibrosis, low grade scarring such as, increased fibrosis, keloids, post-surgical scars, wound healing, surgical scarring, fibrosclerosis, scar growth, keloid; Pharmaceutical and biological preparations for veterinary medicine, namely, gene therapy, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy for treatment of genetic disorders, the musculo-skeletal system, namely, connective tissue disease, bone diseases, spinal diseases, rejection of grafts and transplants, and other rare diseases; Pharmaceutical and biological preparations for veterinary medicine for the treatment of central nervous systems diseases, Alzheimer's, Parkinson's,respiratory track diseases, metabolic syndrome, cardiac diseases, skin diseases, cancer, high cholesterol, diabetes, sexually transmitted diseases, autoimmune diseases, multiple sclerosis, free radical oxidation. Pharmaceutical and biological herbicides, pesticides, fungicides for agricultural use, and domestic use
The English translation of Benviva in the mark is Sunlife potentially in esperanto.

Trademark Events
Jan 8, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Jan 8, 2024
Abandonment - No Use Statement Filed
Jun 6, 2023
Noa E-Mailed - Sou Required From Applicant
Apr 11, 2023
Official Gazette Publication Confirmation E-Mailed
Apr 11, 2023
Published For Opposition
Mar 22, 2023
Notification Of Notice Of Publication E-Mailed
Mar 8, 2023
Approved For Pub - Principal Register
Mar 4, 2023
Assigned To Examiner
May 23, 2022
New Application Office Supplied Data Entered
May 19, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24